Jim Simons
LABD icon

Jim Simons’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Jim Simons’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
+47,500
New +$639K ﹤0.01% 2716
2020
Q4 		– Sell
-787
Closed -$470K – 3570
2020
Q3 		$470K Buy
+787
New +$508K ﹤0.01% 2830

Other funds holding LABD

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PS
PayPay Securities Tokyo, Japan $4.1M AUM 0.16% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Jim Simons's LABD Position: Q2 2026 in Review

Jim Simons opened a new position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2026: 47,500 shares worth $366K. The stake represents ﹤0.01% of the portfolio and ranks #2716 among its holdings. This is a return to the name: Jim Simons previously reported a position in LABD as recently as Q3 2020.

Jim Simons first reported a position in LABD in Q3 2020 and has held it in 2 quarters since. The position peaked at $470K in Q3 2020. 9 funds tracked by Wall St. Rank hold LABD as of Q2 2026.

  • Jim Simons held 47,500 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $366K as of Q2 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF was a new Jim Simons position in Q2 2026.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2716 holding.
  • Jim Simons first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2020 and has held it in 2 quarters since.
  • Jim Simons's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $470K in Q3 2020.
  • 9 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.